SAN FRANCISCO–(BUSINESS WIRE)–CellViva, a biopharmaceutical company pioneering the development of an innovative anti-VEGF therapy for pterygium—an unmet medical need in ophthalmology, is proud to announce the appointment of three distinguished leader…
Category: Business
Ora & BlindCAN Evolve Purpose-Driven Initiative, The Blind Canvas Project, in Collaboration With Academy of Music for the Blind
BOSTON–(BUSINESS WIRE)– #blindcanvasproject–Ora announces the next chapter of groundbreaking initiative Blind Canvas Project, in collaboration with the Academy of Music for the Blind (AMB).
Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that an affiliate has acquired Elios Vision, Inc., developer of th…
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders: To My Fellow Stockholders, You hav…
World-Renowned Moorfields Eye Hospital to Implement MEDITECH Expanse Electronic Patient Record (EPR)
CANTON, Mass.–(BUSINESS WIRE)–Moorfields Eye Hospital NHS Foundation Trust will implement MEDITECH’s Expanse EPR in their 20 locations.
NationsBenefits® Announces Acquisition of General Vision Services, Expanding Vision Solutions to Medicare Advantage Customers
PLANTATION, Fla.–(BUSINESS WIRE)– #HealthcareInnovation–NationsBenefits announces the acquisition of General Vision Services (GVS), expanding supplemental benefits platform to include managed vision care.
L'EXCELLENCE DE LA TECHNOLOGIE LASER DE DEKA POURSUIT SON EXPANSION EN FRANCE ET AU MAGHREB
LYON, France–(BUSINESS WIRE)–Avec pour objectif l’innovation et la satisfaction de ses clients, DEKA, faisant partie du groupe multinational El.En., coté au segment Euronext Star de la Bourse Italienne, continue de transformer le paysage des applicat…
DEKA'S EXCELLENCE IN LASER TECHNOLOGY CONTINUES TO EXTEND ACROSS FRANCE AND NORTH AFRICA
LYON, France–(BUSINESS WIRE)– #CO2–With its focus on innovation and customer satisfaction, DEKA, which is part of the multinational El.En. group, listed on the Euronext Star segment of the Italian Stock Exchange, continues to transform the laser app…
ソウル半導体、欧州における最終検査員の目の保護強化に新技術で対応
韓国ソウル–(BUSINESS WIRE)–（ビジネスワイヤ） — 欧州の主要自動車メーカーは、最終出荷検査ラインで検査員の目を保護しつつ、車両の微細な塗装欠陥の検出を容易にするため、自然光のスペクトルを再現した照明の必要性を認識しており、ソウル半導体はこれに応え、SunLike照明技術を導入しました。 ソウル半導体（KOSDAQ：046890）とドイツの照明専門会社であるブロール・システムテクニックは22日の発表で、量産工場の出荷ラインで同技術を用いた検査が行われていることを明らかにしました…
Seoul Semiconductor: Europe Enhances Eye Protection for Final Inspection Inspectors
SEOUL, South Korea–(BUSINESS WIRE)– #AutomobileManufacturing–Seoul Semiconductor’s SunLike technology protects the eyesight of the inspectors in European automobile factories.
Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced a favorable jury verdict in the case of ImprimisRx, LLC v. OSRX, Inc. ImprimisRx, a wholly owned subsidiary of …
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
NASHVILLE, Tenn.–(BUSINESS WIRE)–Melt Pharmaceuticals, Inc. (“Melt”), a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced positive topline results of its pivotal Phase 3 study evaluating the sa…
Health Network One Names Heyward Donigan as New CEO
FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–Health Network One names Heyward Donigan CEO effective Jan 1. Current CEO Luis Mosquera transitions to Exec. Chairman of the Board.
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
MediPrint Ophthalmics Presents Promising Results from Phase 2b Clinical Trial of LL-BMT1 for Glaucoma at American Academy of Optometry
INDIANAPOLIS–(BUSINESS WIRE)– #clinicaltrial–MediPrint® Ophthalmics (MediPrint), a clinical-stage ophthalmic drug delivery company based in San Diego, announced the results of the Company’s Phase 2b clinical trial of LL-BMT1. Employing a novel 3D pr…
CareSource Expands Benefits for Dual Eligible Georgians, Offering Additional Savings and Increased Healthy Benefits Allowance
ATLANTA–(BUSINESS WIRE)–CareSource, a nationally recognized nonprofit health plan serving more than 440,000 Georgians, announced an enhanced benefits package for its Dual Eligible Special Needs Plan (DSNP). The plan is designed to help members lead h…
Glaukos Announces Participation in Upcoming Investor Conferences
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., an innovator in sustained drug delivery for chronic retinal diseases, today announced that the U.S. Food and Drug Administration (FDA), has extended the Prescription Drug User Fee Act …
Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
GENEVA–(BUSINESS WIRE)–Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh